Wangda Zhou

Evaluation of Aztreonam Dosing Regimens in Patients With Normal and Impaired Renal Function: A Population Pharmacokinetic Modeling and Monte Carlo Simulation Analysis

Diansong Zhou, Hongmei Xu, N. Al-Huniti, 2017, Journal of clinical pharmacology.

Utilization of physiologically‐based pharmacokinetic model to assess disease‐mediated therapeutic protein‐disease‐drug interaction in immune‐mediated inflammatory diseases

Honghui Zhou, Yang Chen, Xin Miao, 2021, Clinical and translational science.

Extrapolating Pharmacodynamic Effects From Adults to Pediatrics: A Case Study of Ustekinumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis

Amarnath Sharma, Honghui Zhou, Zhenhua Xu, 2020, Clinical pharmacology and therapeutics.

Phase 1–2 safety, efficacy and pharmacokinetic study of decitabine in sequential administration with cytarabine in children with relapsed or refractory acute myeloid leukaemia

P. Kearns, D. Reinhardt, C. Zwaan, 2019, British journal of haematology.

Model‐informed bridging of rivaroxaban doses for thromboprophylaxis in pediatric patients aged 9 years and older with congenital heart disease

Yang Zhang, T. Post, J. Lippert, 2022, CPT: pharmacometrics & systems pharmacology.

Dosing Regimen Prediction and Confirmation With Rivaroxaban for Thromboprophylaxis in Children After the Fontan Procedure: Insights From the Phase III UNIVERSE Study

B. McCrindle, L. Lesko, A. Michelson, 2021, Journal of clinical pharmacology.

Development of a physiologically based pharmacokinetic model to predict the effects of flavin‐containing monooxygenase 3 (FMO3) polymorphisms on itopride exposure

Diansong Zhou, S. Neuhoff, N. Al-Huniti, 2017, Biopharmaceutics & drug disposition.

Population Pharmacokinetic Analysis of Decitabine in Pediatric Patients With Acute Myeloid Leukemia

I. Poggesi, D. Parasrampuria, Liping Zhang, 2018, Journal of clinical pharmacology.